Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

NCT06852378 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-03-04

No results posted yet for this study

Summary

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Conditions

  • Iliopsoas Nerve Block
  • Femoral Nerve Block
  • Hip Fracture Surgeries

Interventions

DRUG

Iliopsoas nerve block

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

DRUG

Femoral nerve block

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06852378 on ClinicalTrials.gov